← Leaderboards
David Beasley
University Of Texas Medical Br Galveston
$21,354,410
Attributed
$21,354,410
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,354,410 · 8
By mechanism
UC7$10,613,463 · 4
N01$10,248,302 · 2
R21$410,815 · 1
U54$81,830 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Scott C Weaver$56,593,623
- Elena I Frolova$7,924,153
- Ilya V. Frolov$8,182,660
- David H Walker$27,320,724
- Slobodan Paessler$18,721,420
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelStandardizationContractsLicensureEfficacy TestingInfectious Disease ModelCommunicable DiseasesResearch PersonnelAnimal Model DevelopmentLaboratoriesTherapeutic DevelopmentEnsureOperationProduct DevelopmentNational Institute Of Allergy And Infectious DiseaseVaccinesBiodefenseMouse ModelFundingDiagnosticTherapeutic EvaluationTraining And EducationEmerging Communicable DiseasesResearch Infrastructure
Grant awards (42)
Core E - Regulatory Compliance Core$679,447
UC7 · FY2025 · AI · contact PI
Task B16: Model Development and Medical Countermeasures (MCMs) for BSL-4 Agents in NHPs$1,610,509
N01 · FY2024 · AI · contact PI
Core E - Regulatory Compliance Core$595,244
UC7 · FY2024 · AI · contact PI
Core E - Regulatory Compliance Core$605,075
UC7 · FY2023 · AI · contact PI
Task A79: Therapeutics testing in animal models$123,725
N01 · FY2023 · AI · contact PI
Core E - Regulatory Compliance Core$602,588
UC7 · FY2022 · AI · contact PI
Core E - Regulatory Compliance Core$641,920
UC7 · FY2021 · AI · contact PI
TASK A04: EVALUATION OF THERAPEUTICS IN MOUSE MODELS OF DENGUE VIRUS$316,646
N01 · FY2021 · AI · contact PI
Task C11: Using a Human Lung Microphysiologic System to Model SARS-CoV-2 Infection and Test Candidate Countermeasures$228,471
N01 · FY2021 · AI · contact PI
TASK A04: EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS$798,251
N01 · FY2020 · AI · contact PI
Regulatory Compliance Core - Galveston National Laboratory BSL4 Operations$673,879
UC7 · FY2020 · AI · contact PI
Task C11: Using a Human Lung Microphysiologic System to Model SARS-CoV-2 Infection and Test Candidate Countermeasures$470,308
N01 · FY2020 · AI · contact PI
Task A02: Murine models of Ascending UTI Infection caused by Drug-Resistant Bacteria$276,917
N01 · FY2020 · AI · contact PI
TASK A04: EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS$789,448
N01 · FY2019 · AI · contact PI
Regulatory Compliance Core - Galveston National Laboratory BSL4 Operations$657,107
UC7 · FY2019 · AI · contact PI
Task A02: Murine models of Ascending UTI Infection caused by Drug-Resistant Bacteria$579,891
N01 · FY2019 · AI · contact PI
TASK A07: Rodent models for testing therapeutics against Filoviruses$167,026
N01 · FY2019 · AI · contact PI
TASK A04: EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS$875,449
N01 · FY2018 · AI · contact PI
Regulatory Compliance Core - Galveston National Laboratory BSL4 Operations$594,012
UC7 · FY2018 · AI · contact PI
TASK A07: Rodent models for testing therapeutics against Filoviruses$577,799
N01 · FY2018 · AI · contact PI
Task A02: Murine models of Ascending UTI Infection caused by Drug-Resistant Bacteria$302,974
N01 · FY2018 · AI · contact PI
Task B1: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT$2,909
N01 · FY2018 · AI · contact PI
Task C01: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT$1,455
N01 · FY2018 · AI · contact PI
Regulatory Compliance Core - Galveston National Laboratory BSL4 Operations$705,217
UC7 · FY2017 · AI · contact PI
Task 2: Murine models of Ascending UTI Infection caused by Drug-Resistant Bacteria$627,668
N01 · FY2017 · AI · contact PI
TASK A94: Mouse Models for Therapeutics Testing Against Ebola Virus$267,475
N01 · FY2017 · AI · contact PI
Task A68: Refinement of small animal model potency assays for Filovirus challenge material$197,699
N01 · FY2017 · AI · contact PI
ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT$3,500
N01 · FY2017 · AI · contact PI
Task A71: Evaluation of Therapeutics and Vaccines in Mouse Models of Dengue Virus$2,953
N01 · FY2017 · AI · contact PI
TASK A94: Mouse Models for Therapeutics Testing Against Ebola Virus$2,854
N01 · FY2017 · AI · contact PI
TASK A94: Mouse Models for Therapeutics Testing Against Ebola Virus$971,620
N01 · FY2016 · AI · contact PI
TASK A74: Small Animal Screening Models to Assess New and Innovative Drug Candidates Against Bacillus Anthracis$701,677
N01 · FY2016 · AI · contact PI
Regulatory Compliance Core - Galveston National Laboratory BSL4 Operations$661,543
UC7 · FY2016 · AI · contact PI
Task A68: Refinement of small animal model potency assays for Filovirus challenge material$351,078
N01 · FY2016 · AI · contact PI
Regulatory Compliance$834,928
UC7 · FY2015 · AI · contact PI
Regulatory Compliance$622,710
UC7 · FY2014 · AI · contact PI
Regulatory Compliance$832,398
UC7 · FY2013 · AI · contact PI
Regulatory Compliance$874,097
UC7 · FY2012 · AI · contact PI
Regulatory Compliance$1,033,298
UC7 · FY2011 · AI · contact PI
Recombinant antigen-based assays for flavivirus serodiagnosis and surveillance$81,830
U54 · FY2008 · AI · contact PI
Attenuated West Nile virus envelope protein mutants$184,315
R21 · FY2006 · AI · contact PI
Attenuated West Nile virus envelope protein mutants$226,500
R21 · FY2005 · AI